Driehaus Small Cap Growth Fund Investor Class (DVSMX)

Fund Assets	1.57B
Expense Ratio	0.929%
Min. Investment	$10,000
Turnover	152.00%
Dividend (ttm)	0.06
Dividend Yield	0.21%
Dividend Growth	-77.38%
Payout Frequency	Annual
Ex-Dividend Date	Dec 18, 2025

Previous Close	27.57
YTD Return	0.82%
1-Year Return	0.74%
5-Year Return	16.19%
52-Week Low	24.53
52-Week High	33.35
Beta (5Y)	1.18
Holdings	128
Inception Date	Aug 21, 2017

About DVSMX

Driehaus Small Cap Growth Fund Investor Class is a mutual fund focused on maximizing capital appreciation through investments in U.S. small-capitalization companies. The fund primarily employs a growth-oriented strategy, targeting equity securities of businesses that generally fall within the market capitalization range of the Russell 2000 Growth Index at the time of investment. It seeks to identify dynamic and innovative companies with above-average growth prospects across sectors such as healthcare, industrials, consumer cyclical, and technology. Managed by a seasoned investment team, the fund diversifies across numerous holdings and maintains a relatively high portfolio turnover, which reflects its active approach to capturing growth opportunities. With a below-average expense ratio relative to its peer group, the fund appeals to investors seeking exposure to the small growth segment of the market. Driehaus Small Cap Growth Fund Investor Class plays a significant role for investors aiming to participate in the potential outperformance and higher volatility typically associated with small-cap growth stocks, thereby serving as an important allocation within a diversified portfolio.

• Fund Family: Driehaus
• Category: Small Growth
• Performance Rating: Above Average
• Risk Rating: High
• Stock Exchange: Nasdaq
• Ticker Symbol: DVSMX
• Share Class: Investor Share Class
• Index: Russell 2000 Growth TR

Performance

DVSMX had a total return of 0.74% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.24%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
DNSMX	Institutional Share Class	0.69%

Top 10 Holdings

18.51% of assets

Name	Symbol	Weight
Northern Institutional US Govt Sel	BGSXX	2.63%
Guardant Health, Inc.	GH	2.40%
Spyre Therapeutics, Inc.	SYRE	2.11%
Crinetics Pharmaceuticals, Inc.	CRNX	1.83%
Praxis Precision Medicines, Inc.	PRAX	1.80%
Definium Therapeutics, Inc.	DFTX	1.79%
Xenon Pharmaceuticals Inc.	XENE	1.61%
Curtiss-Wright Corporation	CW	1.59%
Edgewise Therapeutics, Inc.	EWTX	1.39%
Twist Bioscience Corporation	TWST	1.37%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 18, 2025	$0.05609	Dec 18, 2025
Dec 19, 2024	$0.24802	Dec 19, 2024
Dec 13, 2023	$0.06932	Dec 14, 2023
Dec 14, 2022	$0.32916	Dec 14, 2022
Dec 16, 2021	$4.52268	Dec 17, 2021
Dec 17, 2020	$1.5477	Dec 17, 2020

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Oct 16, 2026

Data Sources Report a data error